Production (Stage)
Addex Therapeutics Ltd
ADXN
$8.40
$0.192.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.37M | -1.77M | 14.24M | -3.53M | -3.23M |
| Total Depreciation and Amortization | 27.10K | 61.90K | 124.30K | 3.40K | 3.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 819.90K | 1.09M | -14.80M | 374.00K | 732.40K |
| Change in Net Operating Assets | 499.20K | 152.30K | -2.61M | 643.80K | 1.79M |
| Cash from Operations | -26.80K | -460.80K | -3.05M | -2.51M | -703.60K |
| Capital Expenditure | 0.00 | -1.50K | -- | -- | -1.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.10K | -5.30K | 5.16M | -- | -- |
| Cash from Investing | -18.10K | -6.80K | 5.16M | -- | -1.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.80K | -2.20K | -3.00K | -66.70K | -69.10K |
| Issuance of Common Stock | 1.60K | 2.20K | 400.00 | 236.80K | 16.70K |
| Repurchase of Common Stock | 0.00 | 0.00 | -21.20K | -4.50K | -3.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.50K | -500.00 | -33.60K | -1.00K | -2.70K |
| Cash from Financing | -2.00K | -600.00 | -63.50K | 188.20K | -65.90K |
| Foreign Exchange rate Adjustments | 38.40K | -38.90K | 1.80K | 112.10K | -232.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | 338.20K | -349.80K | -- |
| Net Change in Cash | -8.50K | -507.10K | 2.39M | -2.56M | -1.00M |